Regulatory Effects of CD14 + CD16 ++ Slan + Monocytes on Classical Monocytes and T Lymphocytes in Response to Inflammatory and Phagocytic Stimuli
Journal of Immunology Research · 2026-01 · 2026 (1)
DOI: 10.1155/jimr/3322498 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Immunology Research, online erschienen am 11.04.2026. Verfasst von Cristian A Anacona und 3 weiteren Autor:innen. Beteiligte Einrichtung: Cellular Immunology and Immunogenetics Group, Faculty of Medicine, University of Antioquia, Medellín, Colombia, udea.edu.co. Hauptthemen laut MEDLINE: Monocytes, T-Lymphocytes, Inflammation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: MINCIENCIAS, Immunology and Immunogenetics Research Group (GICIG).
Abstract (Originalsprache)
Background
CD14 + CD16 ++ 6‐sulfo LacNAc (Slan) + monocytes represent a specialized nonclassical subset with reported pro‐inflammatory and regulatory features. However, their capacity to modulate classical monocytes and T lymphocytes under apoptotic and inflammatory conditions remains incompletely defined.
Methods
We employed a coculture reconstitution model using flow cytometry—sorted CD14 + CD16 ++ Slan + monocytes and CD14 ++ CD16 - Slan − classical monocytes at defined ratios. Cultures were stimulated with lipopolysaccharide (LPS) or K562‐derived apoptotic bodies (ABs). Monocyte surface marker expression was evaluated by flow cytometry, and cytokine concentrations were quantified using multiplex bead‐based assays. The impact of Slan + monocytes on CD3 + T cell proliferation and cytokine production was assessed following monocyte–T cell coculture.
Results
CD14 + CD16 ++ Slan + monocytes exhibited enhanced uptake of ABs and distinct phenotypic modulation upon stimulation. Increasing proportions of Slan + cells induced higher HLA‐DR and CCR5 expression on classical monocytes. LPS stimulation promoted TNF, IL‐12, IL‐6, and CCL2 production, whereas AB exposure favored IL‐10 and IL‐17 accumulation. In coculture assays, Slan + monocytes reduced CD4 + and CD8 + T cell proliferation and altered T cell cytokine profiles in a stimulus‐dependent manner.
Conclusion
CD14 + CD16 ++ Slan + monocytes exert a dose‐ and context‐dependent modulatory effect on classical monocytes and T lymphocytes in vitro, displaying both inflammatory and regulatory properties depending on the stimulus. These findings highlight their functional plasticity within the human monocyte compartment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cellular Immunology and Immunogenetics Group, Faculty of Medicine, University of Antioquia, Medellín, Colombia, udea.edu.co.
- Rheumatology Section, San Vicente Fundación University Hospital, Medellín, Colombia.
- Flow Cytometry Unit, University Research Center, University of Antioquia, Medellín, Colombia, udea.edu.co.
ORCID-Profile: Cristian A Anacona, Karen Álvarez, Gloria Vásquez, Mauricio Rojas
Förderung
- MINCIENCIAS
- Immunology and Immunogenetics Research Group (GICIG)
Zitieren
APA
Anacona, C. A., Álvarez, K., Vásquez, G., & Rojas, M. (2026). Regulatory Effects of CD14 + CD16 ++ Slan + Monocytes on Classical Monocytes and T Lymphocytes in Response to Inflammatory and Phagocytic Stimuli. Journal of Immunology Research, 2026(1). https://doi.org/10.1155/jimr/3322498
Vancouver
Anacona CA, Álvarez K, Vásquez G, Rojas M. Regulatory Effects of CD14 + CD16 ++ Slan + Monocytes on Classical Monocytes and T Lymphocytes in Response to Inflammatory and Phagocytic Stimuli. Journal of Immunology Research. 2026;2026(1). doi:10.1155/jimr/3322498
BibTeX
@article{Anacona2026,
author = {Anacona, Cristian A and Álvarez, Karen and Vásquez, Gloria and Rojas, Mauricio},
title = {Regulatory Effects of CD14 + CD16 ++ Slan + Monocytes on Classical Monocytes and T Lymphocytes in Response to Inflammatory and Phagocytic Stimuli},
journal = {Journal of Immunology Research},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/jimr/3322498}
}
EUVIMED